← All stocks

Damora Therapeutics, Inc.

DMRA Net buying
CIK 0001800315 #2097 in the set updated 17 Sep 2026
Bought (120 mo)
$28.14M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.34M
$0.00 on a plan · $38.79K straight out of an exercise
Sold at will
$2.31M
37 of 46 sales
Net
+$25.80M
+$25.83M against sales at will

By person

17 insiders · 63 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Khuong Chau Quang
Director
$11.00M (2)
+$11.00M
1,031,811
$30.93M
ORBIMED ADVISORS LLC entity
10% owner
$11.00M (2)
$2.30M (36)
+$8.70M
2,542,186
$76.21M
+943.8%
Novo Holdings A/S entity
10% owner
$5.00M (1)
+$5.00M
2,497,791
$74.88M
Christgau Stephan
Director
$999.99K (1)
+$999.99K
546,136
$16.37M
Lindmark Bertil
Chief Medical Officer
$42.06K (2)
+$42.06K
16,604
$497.79K
Freve Jonathan
Chief Financial Officer
$41.40K (4)
+$41.40K
12,000
$359.76K
Schambye Hans T.
Chief Executive Officer
$41.83K (3)
$24.96K (3) scheduled
+$16.87K
4,682
$140.37K
Firmani Lori
Chief Financial Officer
$4.86K (3) scheduled
−$4.86K
931
$27.91K
Winslow Garrett
General Counsel
$14.56K (2)
$16.32K (4) scheduled
−$1.76K
2,289
$68.62K
Fairmount Funds Management LLC entity
Director
2,904,000
$87.06M
Jarrett Jennifer
See Remarks
500,000
$14.99M
Hewes L. Becker
Chief Medical Officer
264,629
$7.93M
Sattarzadeh Sherwin
Chief Operating Officer
190,376
$5.71M
Bruno Julianne
Director
137,032
$4.11M
+1,606%
GOLDFISCHER CARL
Director
29,019
$869.99K
Munshi Amit
Director
4,793
$143.69K
Pedersen Anders
Chief Operating Officer
3,746
$112.31K

No percentages here. This company's share count has moved by a factor of 46.9 over the window, from 1,316,989 to 61,735,519 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Winslow Garrett
6 Jul 2026
General Counsel
Sell
245
$29.98
$7.35K
Firmani Lori
2 Jan 2026
Chief Financial Officer
Sold after exercise
135
$21.41
$2.89K
Winslow Garrett
2 Jan 2026
General Counsel
Sold after exercise
255
$21.38
$5.45K
Schambye Hans T.
2 Jan 2026
Chief Executive Officer
Sold after exercise
700
$21.38
$14.97K
Firmani Lori
3 Jul 2025
Interim CFO
Sold after exercise
147
$3.39
$498.33
Winslow Garrett
3 Jul 2025
General Counsel
Sold after exercise
260
$3.39
$881.40
Schambye Hans T.
3 Jul 2025
Chief Executive Officer
Sold after exercise
735
$3.38
$2.48K
Schambye Hans T.
3 Jan 2025
Chief Executive Officer
Sold after exercise
1,341
$5.60
$7.51K
Firmani Lori
3 Jan 2025
Interim CFO
Sold after exercise
261
$5.63
$1.47K
Winslow Garrett
3 Jan 2025
General Counsel
Sold after exercise
471
$5.60
$2.64K
ORBIMED ADVISORS LLC
15 Aug 2023
10% owner
Sell indirect
535,534
$0.75
$401.65K
ORBIMED ADVISORS LLC
15 Aug 2023
10% owner
Sell indirect
248,819
$0.75
$186.61K
ORBIMED ADVISORS LLC
15 Aug 2023
10% owner
Sell indirect
38,327
$0.75
$28.75K
ORBIMED ADVISORS LLC
31 Jul 2023
10% owner
Sell indirect
153,078
$3.00
$459.23K
ORBIMED ADVISORS LLC
31 Jul 2023
10% owner
Sell indirect
29,700
$3.00
$89.10K
ORBIMED ADVISORS LLC
31 Jul 2023
10% owner
Sell indirect
26,622
$3.00
$79.87K
ORBIMED ADVISORS LLC
25 Jul 2023
10% owner
Sell indirect
26,700
$2.92
$77.96K
ORBIMED ADVISORS LLC
25 Jul 2023
10% owner
Sell indirect
4,700
$2.92
$13.72K
ORBIMED ADVISORS LLC
25 Jul 2023
10% owner
Sell indirect
7,800
$2.92
$22.78K
ORBIMED ADVISORS LLC
13 Jul 2023
10% owner
Sell indirect
132,100
$2.40
$317.04K
ORBIMED ADVISORS LLC
13 Jul 2023
10% owner
Sell indirect
52,800
$2.40
$126.72K
ORBIMED ADVISORS LLC
13 Jul 2023
10% owner
Sell indirect
9,800
$2.40
$23.52K
ORBIMED ADVISORS LLC
17 Apr 2023
10% owner
Sell indirect
8,878
$1.97
$17.49K
ORBIMED ADVISORS LLC
17 Apr 2023
10% owner
Sell indirect
3,551
$1.97
$7.00K
ORBIMED ADVISORS LLC
17 Apr 2023
10% owner
Sell indirect
660
$1.97
$1.30K
ORBIMED ADVISORS LLC
14 Apr 2023
10% owner
Sell indirect
28,110
$1.86
$52.28K
ORBIMED ADVISORS LLC
14 Apr 2023
10% owner
Sell indirect
11,245
$1.86
$20.92K
ORBIMED ADVISORS LLC
14 Apr 2023
10% owner
Sell indirect
2,091
$1.86
$3.89K
ORBIMED ADVISORS LLC
13 Apr 2023
10% owner
Sell indirect
9,459
$1.82
$17.22K
ORBIMED ADVISORS LLC
13 Apr 2023
10% owner
Sell indirect
3,784
$1.82
$6.89K
ORBIMED ADVISORS LLC
13 Apr 2023
10% owner
Sell indirect
703
$1.82
$1.28K
ORBIMED ADVISORS LLC
12 Apr 2023
10% owner
Sell indirect
1,603
$1.81
$2.90K
ORBIMED ADVISORS LLC
12 Apr 2023
10% owner
Sell indirect
641
$1.81
$1.16K
ORBIMED ADVISORS LLC
12 Apr 2023
10% owner
Sell indirect
119
$1.81
$215.39
ORBIMED ADVISORS LLC
11 Apr 2023
10% owner
Sell indirect
9,459
$1.82
$17.22K
ORBIMED ADVISORS LLC
11 Apr 2023
10% owner
Sell indirect
3,784
$1.82
$6.89K
ORBIMED ADVISORS LLC
11 Apr 2023
10% owner
Sell indirect
703
$1.82
$1.28K
ORBIMED ADVISORS LLC
10 Apr 2023
10% owner
Sell indirect
34,745
$1.79
$62.19K
ORBIMED ADVISORS LLC
10 Apr 2023
10% owner
Sell indirect
13,899
$1.79
$24.88K
ORBIMED ADVISORS LLC
10 Apr 2023
10% owner
Sell indirect
2,584
$1.79
$4.63K
ORBIMED ADVISORS LLC
6 Apr 2023
10% owner
Sell indirect
6,558
$2.00
$13.12K
ORBIMED ADVISORS LLC
6 Apr 2023
10% owner
Sell indirect
2,620
$2.00
$5.24K
ORBIMED ADVISORS LLC
6 Apr 2023
10% owner
Sell indirect
487
$2.00
$974.00
ORBIMED ADVISORS LLC
5 Apr 2023
10% owner
Sell indirect
63,058
$2.18
$137.47K
ORBIMED ADVISORS LLC
5 Apr 2023
10% owner
Sell indirect
25,220
$2.18
$54.98K
ORBIMED ADVISORS LLC
5 Apr 2023
10% owner
Sell indirect
4,687
$2.18
$10.22K
Schambye Hans T.
22 Mar 2022
Chief Executive Officer
Buy
5,000
$2.15
$10.75K
Lindmark Bertil
22 Mar 2022
Chief Medical Officer
Buy
14,604
$2.16
$31.54K
Freve Jonathan
3 Dec 2021
Chief Financial Officer
Buy
4,000
$2.49
$9.96K
Winslow Garrett
3 Dec 2021
General Counsel
Buy
2,000
$2.48
$4.96K
Schambye Hans T.
9 Nov 2021
Chief Executive Officer
Buy
4,500
$3.50
$15.75K
Freve Jonathan
8 Nov 2021
Chief Financial Officer
Buy
3,000
$3.40
$10.20K
Freve Jonathan
18 Aug 2021
Chief Financial Officer
Buy
3,000
$3.92
$11.76K
Lindmark Bertil
28 Jun 2021
Chief Medical Officer
Buy
2,000
$5.26
$10.52K
Schambye Hans T.
24 Jun 2021
Chief Executive Officer
Buy
3,000
$5.11
$15.33K
Winslow Garrett
23 Jun 2021
General Counsel
Buy
2,000
$4.80
$9.60K
Freve Jonathan
23 Jun 2021
Chief Financial Officer
Buy
2,000
$4.74
$9.48K
Novo Holdings A/S
2 Nov 2020
10% owner
Buy
333,333
$15.00
$5.00M
Christgau Stephan
2 Nov 2020
Director
Buy indirect
66,666
$15.00
$999.99K
Khuong Chau Quang
2 Nov 2020
Director
Buy indirect
209,500
$15.00
$3.14M
Khuong Chau Quang
2 Nov 2020
Director
Buy indirect
523,833
$15.00
$7.86M
ORBIMED ADVISORS LLC
2 Nov 2020
Director
Buy indirect
209,500
$15.00
$3.14M
ORBIMED ADVISORS LLC
2 Nov 2020
Director
Buy indirect
523,833
$15.00
$7.86M

What was left out

Form 4 filings counted 105
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 10
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 9
Sales at will 37
Transactions with no price 0
Shares from compensation/vesting 19,662,496
History held since 4 Nov 2020